Inflammatory signaling compromises cell responses to interferon alpha
Open Access
- 13 June 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 31 (2), 161-172
- https://doi.org/10.1038/onc.2011.221
Abstract
Interferon alpha (IFNα) is widely used for treatment of melanoma and certain other malignancies. This cytokine as well as the related IFNβ exerts potent anti-tumorigenic effects; however, their efficacy in patients is often suboptimal. Here, we report that inflammatory signaling impedes the effects of IFNα/β. Melanoma cells can secrete pro-inflammatory cytokines that inhibit cellular responses to IFNα/β via activating the ligand-independent pathway for the phosphorylation and subsequent ubiquitination and accelerated degradation of the IFNAR1 chain of type I IFN receptor. Catalytic activity of the p38 protein kinase was required for IFNAR1 downregulation and inhibition of IFNα/β signaling induced by proinflammatory cytokines such as interleukin 1 (IL-1). Activation of p38 kinase inversely correlated with protein levels of IFNAR1 in clinical melanoma specimens. Inhibition of p38 kinase augmented the inhibitory effects of IFNα/β on cell viability and growth in vitro and in vivo. The roles of inflammation and p38 protein kinase in regulating cellular responses to IFNα/β in normal and tumor cells are discussed.This publication has 83 references indexed in Scilit:
- Immunity, Inflammation, and CancerCell, 2010
- Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1βOnline Journal of Public Health Informatics, 2010
- Reproducibility of serum cytokines and growth factorsCytokine, 2009
- Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseasesProteomics – Clinical Applications, 2008
- Cancer-related inflammationNature, 2008
- Ligand-independent pathway that controls stability of interferon alpha receptorBiochemical and Biophysical Research Communications, 2008
- Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cellsOncogene, 2006
- p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapyThe EMBO Journal, 2006
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- The Hallmarks of CancerCell, 2000